Leber's hereditary optic neuropathy (LHON) is a genetic disease leading to the loss of central vision and optic nerve atrophy. The existence of occasional cases of LHON patients developing a Multiple Sclerosis (MS)-like illness and the hypothesis that mtDNA variants may be involved in MS suggest the possibility of some common molecular mechanisms linking the two diseases. We have pursued a comparative proteomics approach on cerebrospinal fluid (CSF) samples from LHON and MS patients, as well as healthy donors by employing 2-DE gel separations coupled to MALDI-TOF-MS and nLC-MS/MS investigations. 7 protein spots showed significant differential distribution among the three groups. Both CSF of LHON or MS patients are characterized by lower level of transthyretin dimer adduct while a specific up regulation of Apo A-IV was detected in LHON CSF.
Introduction
Leber's hereditary optic neuropathy (LHON), the first disease to be linked with a maternally inherited mtDNA point mutation (Wallace et al., 1988) , is a genetic form of retinal ganglion cell degeneration leading to loss of central vision and optic nerve atrophy occurring predominantly in young males (Riordan-Eva and Harding, 1995) . A subset of LHON patients present extraocular symptoms involving the central nervous system (CNS) and these cases are referred to as LHON "plus" (Riordan-Eva and Harding, 1995) . Amongst the LHON "plus" cases a specific phenotype is the association of LHON with a disorder indistinguishable from Multiple Sclerosis (MS) (Harding et al., 1992) .
Three pathogenic point mutations at nucleotides 11,778, 3460 and 14,484 of mtDNA, affecting, respectively, ND4, ND1 and ND6 subunit genes of complex I of the respiratory chain,
